Sort
25,944 grants matching “neurodegeneration”
First-in-Human (Phase 1) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of IBC-Ab002 in Persons with Early Alzheimer's Disease (AD)
$2,234,624Eti Yoles · Immunobrain Checkpoint Inc. · R01 · FY2022 · AG
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study
$2,234,180Reisa A. Sperling · Massachusetts General Hospital · P01 · FY2018 · AG
Identification of plasma lipoprotein proteins and lipids as biomarkers of innate-immunity and vascular contributions to Alzheimer's disease and Alzheimer's disease-related dementias in older adults
$2,232,476Danni Li · University Of Minnesota · RF1 · FY2023 · AG
Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission
$2,232,255Jessica Kirkland Caldwell · Cleveland Clinic Foundation · P20 · FY2023 · GM
In vivo Identification of Pre-Atrophic Brain Neurodegeneration in Prodromal Alzheimer Disease with Quantitative Gradient Recalled Echo MRI
$2,231,917Dmitriy A Yablonskiy · Washington University · RF1 · FY2022 · AG
The Function and Mechanisms of Autophagy in Spinal Cord Injury
$2,231,793Junfang Wu · University Of Maryland Baltimore · RF1 · FY2022 · NS
Mechanisms of Angiotensin I Converting Enzyme in Alzheimer's disease
$2,231,406Robert J Vassar · Northwestern University At Chicago · RF1 · FY2023 · AG
COBRE GRANT
$2,230,641Jeffrey L. Cummings · Cleveland Clinic Foundation · P20 · FY2017 · GM
Proteopathies of the Aging Central Nervous System
$2,224,187J. David Gladstone Institutes · P01 · FY2003 · AG
Autophagy, Inflammation and Metabolism (AIM) in Disease Center
$2,224,034Vojo P Deretic · University Of New Mexico Health Scis Ctr · P20 · FY2018 · GM
ILLUMINATING CELLULAR AGING PATHWAYS THROUGH GAMETOGENESIS
$2,223,433Elcin Unal · University Of California Berkeley · DP2 · FY2016 · AG
Multiscale chemical approaches to map oxidative stress
$2,222,098Brent Randall Martin · University Of Michigan At Ann Arbor · DP2 · FY2014 · GM
NIEHS Cryo-EM Core Facility
$2,221,037Mario Borgnia · National Institute Of Environmental Health Sciences · ZIC · FY2025 · ES
Senescent cell mapping, identification and validation for human somatic and reproductive tissues
$2,220,833Birgit Schilling · Buck Institute For Research On Aging · U54 · FY2025 · AG
Sepsis and the Systemic Cytokine Storm in Aging and Alzheimer Disease Models
$2,218,350Philip A Efron · University Of Florida · RF1 · FY2022 · NS
Optimization of SHIP1 Inhibitors for the Treatment of Alzheimer's Disease
$2,217,438Timothy I Richardson · Indiana University Indianapolis · U01 · FY2025 · AG
Intranasal Treatment of Stem Cell-derived Extracellular Vesicles for Alzheimer's Disease
$2,212,694Ashok K. Shetty · Texas A&M University Health Science Ctr · RF1 · FY2022 · AG
Parkinson's Disease Research Center of Excellence
$2,210,330Johns Hopkins University · P50 · FY2005 · NS
Generation and characterization of a mouse model exhibiting beta-amyloidosis and tauopathy with nuclear depletion of TDP-43
$2,208,827Philip C Wong · Johns Hopkins University · R61 · FY2019 · NS
Functional and Pharmacological Significance of Receptor Heteromers in the CNS
$2,206,889Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2017 · DA
Molecular Mechanisms linking Aging, Abeta Proteotoxicity and Neurodegeneration
$2,206,194Jeffery W Kelly · Scripps Research Institute, The · P01 · FY2010 · AG
Mentoring Vision Research in Oklahoma
$2,202,727University Of Oklahoma Hlth Sciences Ctr · P20 · FY2004 · RR
Mentoring Vision Research in Oklahoma
$2,202,714University Of Oklahoma Hlth Sciences Ctr · P20 · FY2005 · RR
Mechanistic studies and therapeutics for ALS/FTD linked to UBQLN2 mutations
$2,200,770Mervyn J Monteiro · University Of Maryland Baltimore · RF1 · FY2022 · NS
Autophagy, Inflammation and Metabolism (AIM) in Disease Center
$2,200,660Vojo P Deretic · University Of New Mexico Health Scis Ctr · P20 · FY2020 · GM